We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

111 hedge funds and large institutions have $408M invested in SANGAMO THERAPEUTICS INC in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,513% more call options, than puts

Call options by funds: $82.4M | Put options by funds: $5.11M

144% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 9

70% more capital invested

Capital invested by funds: $240M → $408M (+$168M)

54% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 26

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

12% more funds holding

Funds holding: 99111 (+12)

Holders
111
Holders Change
+12
Holders Change %
+12.12%
% of All Funds
3.6%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
22
Increased
40
Reduced
26
Closed
9
Calls
$82.4M
Puts
$5.11M
Net Calls
+$77.3M
Net Calls Change
+$19.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$2.75M +$420K +42,271 +19%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$2.63M -$1.65M -166,266 -40%
AGA
28
Altrinsic Global Advisors
Connecticut
$2.52M
UOC
29
UBS O'Connor
Illinois
$2.36M +$2.23M +225,000 New
UBS AM
30
UBS AM
Illinois
$2.29M
BBA
31
Baker Bros. Advisors
New York
$1.85M +$1.75M +176,707 New
DCM
32
Driehaus Capital Management
Illinois
$1.82M +$595K +59,945 +53%
BIM
33
BlackRock Investment Management
Delaware
$1.77M +$249K +25,037 +17%
Charles Schwab
34
Charles Schwab
California
$1.67M +$143K +14,414 +12%
FSA
35
Franklin Street Advisors
North Carolina
$1.57M +$278K +28,000 +23%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$1.57M -$1.07M -107,389 -42%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.49M +$165K +16,600 +13%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$1.12M +$134K +13,476 +14%
Ohio Public Employees Retirement System (OPERS)
39
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.04M -$378K -38,079 -28%
TA
40
Teachers Advisors
New York
$1.02M +$24.8K +2,500 +3%
CNB
41
City National Bank
California
$919K -$83.9K -8,450 -9%
AllianceBernstein
42
AllianceBernstein
Tennessee
$897K -$10.2K -1,029 -1%
Wells Fargo
43
Wells Fargo
California
$863K +$72.5K +7,300 +10%
PCMI
44
Princeton Capital Management Inc
New Jersey
$702K +$501K +50,450 +306%
AQR Capital Management
45
AQR Capital Management
Connecticut
$695K
BA
46
BlackRock Advisors
Delaware
$675K +$315K +31,717 +97%
CS
47
Credit Suisse
Switzerland
$667K +$307K +30,877 +94%
ARTA
48
A.R.T. Advisors
New York
$648K +$106K +10,699 +21%
State Board of Administration of Florida Retirement System
49
State Board of Administration of Florida Retirement System
Florida
$638K
Swiss National Bank
50
Swiss National Bank
Switzerland
$581K +$30.8K +3,100 +6%

SGMO Hedge Fund Activity: Q3 2013 in Review

111 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2013, worth a combined $408M — up 70% from $240M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SGMO positions and 9 closed out — a net gain of 13 holders — while 40 added to existing stakes and 26 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $23.1M. The largest seller was RA Capital Management, cutting an estimated $11M.

  • 111 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2013, up from 99 in Q2 2013.
  • Funds reported $408M of SANGAMO THERAPEUTICS INC stock for Q3 2013, up 70% quarter-over-quarter.
  • 22 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2013 and 9 closed out, a net change of +13 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2013 was Adage Capital Partners, an estimated $23.1M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2013 was RA Capital Management, an estimated $11M sold.

Based on aggregated 13F filings for Q3 2013.